Package 60687-793-21

Brand: bupropion hydrochloride

Generic: bupropion hydrochloride
NDC Package

Package Facts

Identity

Package NDC 60687-793-21
Digits Only 6068779321
Product NDC 60687-793
Product ID 60687-793_37b2800f-32bb-1c88-e063-6294a90acfe7
Description

30 BLISTER PACK in 1 CARTON (60687-793-21) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (60687-793-11)

Marketing

Marketing Status
Marketed Since 2024-01-15
Brand bupropion hydrochloride
Generic bupropion hydrochloride
Sample Package No

Linked Drug Pages (1)

Bupropion Hydrochloride ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "37b2800f-32bb-1c88-e063-6294a90acfe7", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993541", "993557"], "spl_set_id": ["8dab6d17-bf41-4a28-90db-b66959c0e143"], "manufacturer_name": ["American Health Packaging"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (60687-793-21)  / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (60687-793-11)", "package_ndc": "60687-793-21", "marketing_start_date": "20240115"}], "brand_name": "Bupropion Hydrochloride", "product_id": "60687-793_37b2800f-32bb-1c88-e063-6294a90acfe7", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "60687-793", "generic_name": "Bupropion Hydrochloride", "labeler_name": "American Health Packaging", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA090693", "marketing_category": "ANDA", "marketing_start_date": "20240115", "listing_expiration_date": "20261231"}